There is emerging evidence that a subset of patients with MCD have autoantibodies against podocyte proteins (for example, nephrin), providing potential links between podocyte injury, autoimmunity, and proteinuria response to anti-B-cell treatment [3]. The gene discussed is NPHS1; the disease is Autoimmunity.